Login Register Cart 0
Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Hypertension-Mediated Organ Damage Detection: The Earlier the Hypertension Treatment, the Better

Author(s): Chrysoula Boutari*, Fotios Siskos and Vasilios G. Athyros

Volume 21, Issue 3, 2023

Published on: 13 June, 2023

Page: [149 - 151] Pages: 3

DOI: 10.2174/1570161121666230525123539

Price: $65

« Previous Next »
[1]
Devereux RB, Alderman MH. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events. Circulation 1993; 88(4): 1444-55.
[http://dx.doi.org/10.1161/01.CIR.88.4.1444]
[2]
Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018; 39(33): 3021-104.
[http://dx.doi.org/10.1093/eurheartj/ehy339] [PMID: 30165516]
[3]
Benas D, Triantafyllidi H, Birmpa D, et al. Increased arterial stiffness associated with blood pressure is the prevalent hypertension mediated organ damage in young patients with first diagnosed and never treated systolic hypertension. Curr Vasc Pharmacol 2023.
[4]
Reibis RK, Huber M, Karoff M, et al. Target organ damage and control of cardiovascular risk factors in hypertensive patients. Herz 2015; 40(S2): 209-16.
[http://dx.doi.org/10.1007/s00059-014-4189-8] [PMID: 25630386]
[5]
Papazafiropoulou A, Skliros E, Sotiropoulos A, et al. Prevalence of target organ damage in hypertensive subjects attending primary care: C.V.P.C. study (epidemiological cardio-vascular study in primary care). BMC Fam Pract 2011; 12(1): 75.
[http://dx.doi.org/10.1186/1471-2296-12-75] [PMID: 21756310]
[6]
Oh JS, Lee CH, Park J, Park HK, Hwang JK. Hypertension-mediated organ damage and long-term cardiovascular outcomes in Asian hypertensive patients without prior cardiovascular disease. J Korean Med Sci 2020; 35(48): e400.
[http://dx.doi.org/10.3346/jkms.2020.35.e400] [PMID: 33316856]
[7]
Maloberti A, Rebora P, Occhino G, et al. Prevalence of hypertension mediated organ damage in subjects with high-normal blood pressure without known hypertension as well as cardiovascular and kidney disease. J Hum Hypertens 2022; 36(7): 610-6.
[http://dx.doi.org/10.1038/s41371-021-00604-6] [PMID: 34493835]
[8]
Cuspidi C, Facchetti R, Bombelli M, et al. High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population. Hypertension 2019; 73(3): 612-9.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.12114] [PMID: 30612493]
[9]
Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. J Am Coll Cardiol 2019; 74(10): e177-232.
[http://dx.doi.org/10.1016/j.jacc.2019.03.010] [PMID: 30894318]
[10]
Vasan RS, Song RJ, Xanthakis V, et al. Hypertension-mediated organ damage: Prevalence, correlates, and prognosis in the community. Hypertension 2022; 79(3): 505-15.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.121.18502] [PMID: 35138872]
[11]
Wu S, Chen D, Zeng X, et al. Arterial stiffness is associated with target organ damage in subjects with pre-hypertension. Arch Med Sci 2018; 14(6): 1374-80.
[http://dx.doi.org/10.5114/aoms.2017.69240] [PMID: 30393492]
[12]
Chrysohoou C, Pitsavos C, Panagiotakos DB, Skoumas J, Stefanadis C. Association between prehypertension status and inflammatory markers related to atherosclerotic disease*1The ATTICA Study. Am J Hypertens 2004; 17(7): 568-73.
[http://dx.doi.org/10.1016/j.amjhyper.2004.03.675] [PMID: 15233975]
[13]
Rizzo M, Obradovic M, Labudovic-Borovic M, et al. Uric acid metabolism in pre-hypertension and the metabolic syndrome. Curr Vasc Pharmacol 2014; 12(4): 572-85.
[http://dx.doi.org/10.2174/1570161111999131205160756] [PMID: 23627979]
[14]
Toikka JO, Laine H, Ahotupa M, et al. Increased arterial intima-media thickness and in vivo LDL oxidation in young men with borderline hypertension. Hypertension 2000; 36(6): 929-33.
[http://dx.doi.org/10.1161/01.HYP.36.6.929] [PMID: 11116102]
[15]
Wright JT Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015; 373(22): 2103-16.
[http://dx.doi.org/10.1056/NEJMoa1511939] [PMID: 26551272]
[16]
Ganotakis E, Papadakis J, Vrentzos G, Mikhailidis D. The effects of antihypertensive therapy on haemostatic parameters. Curr Pharm Des 2003; 9(29): 2445-64.
[http://dx.doi.org/10.2174/1381612033453839] [PMID: 14529558]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy